Muricholic Acid Species Regulation Networks: From Biosynthetic Pathways to Molecular Mechanisms
Bile acids (BAs) are pleiotropic signaling molecules. Muricholic acids (MCAs), a distinct BA subgroup with hydroxyl groups at C3, C6, and/or C7, exhibit structural diversity that underpins functional heterogeneity. This review summarizes MCA species and their derivatives, emphasizing metabolic pathway differences between rodents and humans. We explore gut microbiota-mediated MCA transformation and the associated regulatory networks. MCAs modulate key signaling receptors—farnesoid X receptor (FXR), Takeda G protein-coupled receptor 5 (TGR5), and peroxisome proliferator-activated receptor α (PPARα)—as well as pathways including the gut–liver axis, ceramide metabolism, cyclic guanosine monophosphate–protein kinase G–mechanistic target of rapamycin complex 1 (cGMP–PKG–mTORC1) signaling, and the hypothalamic–pituitary–gonadal (HPG) axis. These actions implicate MCAs in metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), inflammatory bowel disease (IBD), central precocious puberty (CPP). Their potential as diagnostic, predictive, and prognostic biomarkers is also discussed. This synthesis provides a theoretical foundation for understanding MCA-driven disease mechanisms and developing novel therapeutic strategies.
Authors
- 魏丽慧
- Guangzeng Zhou
- Rong Rong (ORCID: https://orcid.org/0000-0003-2423-4082)
- Yan Ni (ORCID: https://orcid.org/0000-0003-1779-7266)
- Mai Han (ORCID: https://orcid.org/0009-0004-9116-3901)
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Children's Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/ijms272210428
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00